Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.
about
Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus.Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?Vaccinomics: current findings, challenges and novel approaches for vaccine developmentImportance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.Variation in vaccine response in normal populations.Consistency of HLA associations between two independent measles vaccine cohorts: a replication studyHuman leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.Variability in Humoral Immunity to Measles Vaccine: New Developments.Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines.Application of pharmacogenomics to vaccines.Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.Personalized vaccinology: A review.Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals.Personalized vaccines: the emerging field of vaccinomics
P2860
Q31007306-04558A1C-471F-480A-9B70-253E18B41CBFQ34126261-B91DF14E-C91D-4105-B38F-FE117AFF70BDQ35176899-1D294DF5-36FD-46C1-91FE-93B47A2CD65BQ35754384-F2C9E94C-6329-43EA-8CF8-860EF62FE655Q35785237-2D46E6AB-5F80-44AB-B602-E7DB376627A2Q35785581-D305341E-5D13-485E-88EE-DA9E4344C712Q35869228-9F5A0012-40E8-4784-A49E-CE5010583864Q36269765-AD0D89AE-1398-4A9F-9C0B-E7A964756AFAQ36373260-C1817BFF-2B4E-45BA-9A15-EC1D2473E504Q36383797-E32DD85D-C2B4-4779-9B22-59584F4D92ADQ37293663-2F589BF1-7910-456A-8B4C-51D1AE8D4F97Q37456000-3AA479A5-CBE3-4F25-997D-5865EF4FAB92Q40107665-1C2C4179-3975-41E4-8F1C-65EE172EF3C0Q42850418-FEAFA782-3EF3-4841-A866-4B5ED4C59697Q57157844-A39C7D0F-469F-4A92-B8C3-0DE6C73B9840
P2860
Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@ast
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@en
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@nl
type
label
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@ast
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@en
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@nl
prefLabel
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@ast
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@en
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@nl
P2860
P50
P1433
P1476
Identification and characteriz ...... us class II HLA-DRB1 peptides.
@en
P2093
David C Muddiman
Kenneth L Johnson
P2860
P356
10.1128/JVI.78.1.42-51.2004
P407
P577
2004-01-01T00:00:00Z